Bristol Myers Squibb Co (NYSE:BMY) is significantly upgrading its computational capabilities by deploying an NVIDIA Corp.
(NASDAQ:NVDA) DGX SuperPOD equipped with DGX Vera Rubin NVL72 systems.
The strategic deployment establishes the most robust and energy-efficient single-owned artificial intelligence infrastructure currently operating within the life sciences sector.
The move builds on the company's broader AI strategy.
In May, Bristol Myers signed a strategic agreement with Anthropic to deploy AI across its operations.
